The thing is, they have been transparent about their intention all along, theyll happily take whatever they can get as they clearly believe that all of the money they are spending on commerciaizing a world first clinical grade passive monitoring remote analysis and diagnosis cloud of devices and algorithms is being well received by all of the industry representations they have been making, and that given how much they already have supported prior placements at elevated prices, and how little support they have received from the market, they want the biggest slice of this possible.
It is all there in black and white. Right down to the admission that it is "not fair, but reasonable".
The downrampers have played into the hands of the board all this time, heck maybe they've even been paid to do it, who knows? One has already admitted their position size is far greater than was typical prior to recent dilution, so they've been spraying negativity for months but obviously accumulating as well. Another just wants the company to fail, has done since 2020. Another seems to have recently changed their disclosure as well, a whole year of "not touching it, overpriced, bad governance" but suddenly declares held.
It isnt exactly top secret info we are talking about, they keep reminding us of the scale of their enterprise and ambition, we just don't seem to believe it.
CDX Price at posting:
5.4¢ Sentiment: Buy Disclosure: Held
